NCT01269905已完成不适用
Choice of Valve Substitute in the Era of Oral Anticoagulation Self-Management
Johann Wolfgang Goethe University Hospital0 个研究点开始时间: 2011年1月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
The optimal valve substitute for patients between 60-70 years is controversial. We compared anticoagulation-related adverse events (ARAE) in patients receiving mechanical heart valve replacement (MHVR) on INR self-management vs. stentless bioprosthesis, to assess whether the risk of structural valve deterioration (SVD) is still out-weighted by the benefit of not requiring permanent anticoagulation.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •heart valve replacement
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Ross for Valve Replacement in AduLts TrialAortic Valve DiseaseNCT03798782Population Health Research Institute43
已完成
不适用
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual CareManagement of AnticoagulationNCT00703963Mayo Clinic200
招募中
不适用
Suppressive Antibiotic Therapy for EndocarditisEndocarditisNCT06107309University Hospital, Strasbourg, France20
Unknown
4 期
Rivaroxaban or Aspirin for Biological Aortic ProsthesisThrombosisAortic StenosisAortic RegurgitationNCT02974920Christian Torp-Pedersen1,000
终止
3 期
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanAortic Valve DiseaseAortic Valve StenosisAortic Valve FailureNCT04142658Artivion Inc.863